These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29397844)

  • 21. Ring chromosome in myeloid neoplasms is associated with complex karyotype and disease progression.
    Rosenbaum MW; Pozdnyakova O; Geyer JT; Dal Cin P; Hasserjian RP
    Hum Pathol; 2017 Oct; 68():40-46. PubMed ID: 28842184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cohort Study on GHA and New Combined Priming Chemotherapeutic Regimens in Treatment of Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome].
    Ma XR; Wang J; Zhang WG; Chen YX; Cao XM; He AL; Liu J; Wang JL; Gu LF; Lei B; Zhang PY; Zhao WH; Yang Y; Wang FX; Xu Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):369-74. PubMed ID: 25948187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
    Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
    J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes.
    Duong VH; Padron E; Al Ali NH; Lancet JE; Hall J; Kwok B; Zhang L; Epling-Burnette PK; List AF; Komrokji RS
    Ann Hematol; 2018 Feb; 97(2):247-254. PubMed ID: 29167940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The relevance between quantitative and type of chromosomal abnormality and leukemia transformation in myelodysplastic syndrome].
    Li Y; Li WW; Wang XM; An L; Liu H; Wang ZS; Xiao ZJ; Qin TJ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):221-4. PubMed ID: 23683420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical Charcteristics and Prognostic Analysis of 28 cases of Pediatric Myelodysplastic Syndrome].
    Wang J; Lin SF; Chen QH; Qiu KY; Xu HG; Huang K; Li Y; Fang JP; Zhou ZD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1695-1701. PubMed ID: 30501706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
    Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical impact of transformation to acute myeloid leukemia in patients with higher-risk myelodysplastic syndromes.
    Kota V; Ogbonnaya A; Farrelly E; Schroader BK; Raju A; Kristo F; Dalal M
    Future Oncol; 2022 Nov; 18(36):4017-4029. PubMed ID: 36622291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. De-novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) and myelodysplastic remission marrow (AML/MRM).
    Tamura S; Kanamaru A
    Leuk Lymphoma; 1995 Jan; 16(3-4):263-70. PubMed ID: 7719234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acquired aplastic anemia developing myelodysplastic syndrome/acute myeloid leukemia: clinical analysis of nineteen patients and literatures review].
    Ma L; Li X; Zhang J; Shao Y; Nie N; Huang Z; Ge M; Zheng Y; Qu D; Shi J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Mar; 36(3):216-20. PubMed ID: 25854465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AML-associated cytogenetic abnormalities (inv (16), del (16), t(8;21)) in patients with myelodysplastic syndromes.
    Estey E; Trujillo JM; Cork A; O'Brien S; Beran M; Kantarjian H; Keating M; Freireich EJ; Stass S
    Hematol Pathol; 1992; 6(1):43-8. PubMed ID: 1601822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Origin and progress of myelodysplastic syndrome with hypoplasia].
    Chen S; Zhu H; Lu R; Gu H; Ge C; Zhang Z
    Zhonghua Nei Ke Za Zhi; 1999 Jun; 38(6):370-2. PubMed ID: 11798668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis.
    Neukirchen J; Lauseker M; Hildebrandt B; Nolting AC; Kaivers J; Kobbe G; Gattermann N; Haas R; Germing U
    Cancer; 2017 Dec; 123(23):4608-4616. PubMed ID: 28746789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia.
    Edlin R; Connock M; Tubeuf S; Round J; Fry-Smith A; Hyde C; Greenheld W
    Health Technol Assess; 2010 May; 14 Suppl 1():69-74. PubMed ID: 20507806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance].
    Wang J; Wang T; Li S; Lin L; Gang Y
    Ai Zheng; 2007 Jan; 26(1):58-63. PubMed ID: 17222369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biological Characteristics and Risk Factors for Prognosis of Myelodysplastic Syndrome].
    Yang YY; Yang JH; Wang D
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1113-1117. PubMed ID: 28823278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunophenotypic characteristics of acute leukaemia after myelodysplastic syndromes.
    Lima M; Teixeira Mdos A; Morais S; Cunha M; Coutinho J; Pinho L; Ribeiro P; Justiça B
    Sangre (Barc); 1995 Feb; 40(1):49-52. PubMed ID: 7716672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndrome.
    Valcárcel D; Ademà V; Solé F; Ortega M; Nomdedeu B; Sanz G; Luño E; Cañizo C; de la Serna J; Ardanaz M; Marco V; Collado R; Grau J; Montoro J; Mallo M; Vallespí T
    J Clin Oncol; 2013 Mar; 31(7):916-22. PubMed ID: 23319689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic Impact of Transformation to Acute Myeloid Leukemia Among Actively Managed Patients with Higher-Risk Myelodysplastic Syndromes in the United States.
    Kota V; Ogbonnaya A; Farrelly E; Schroader BK; Raju A; Kristo F; Dalal M
    Adv Ther; 2023 Apr; 40(4):1655-1669. PubMed ID: 36422807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.